TAKEAWAY: At 1 year, the probability of improving by at least one A1c category was 82.7% with sustained GLP-1 RAs vs 67.1% with sustained DPP-4 inhibitors, with an absolute difference of 15.7% (95% CI, 14.8%-16.5%)
Galen Med J 3(4):207215 Odo S, Tanabe K, Yamauchi M (2013) A pilot clinical trial on l-carnitine supplementation in combination with motivation training: effects on weight management in healthy volunteers
Consider additional metrics such as waist circumference, how clothing fits, and improvements in blood glucose control and overall wellbeing
the regulatory framework is different
What Else You Need to Know: This gentle, hydrating serum delivers clinical-level vitamin C to target stubborn discoloration & sun damage without irritation
The discussion covers why engineered GLP-1 drugs achieve robust brain effects on satiety and food preference that endogenous GLP-1 does not, along with her teams genomic approach to discovering additional peptides that act on distinct brain pathways